NCT05167773 is a clinical trial of tonometer in Intraocular Pressure, sponsored by Topcon Corporation.

Who is sponsoring NCT05167773?

NCT05167773 is sponsored by Topcon Corporation.

What drugs are being tested in NCT05167773?

Interventions in NCT05167773: tonometer.

What condition does NCT05167773 study?

NCT05167773 studies Intraocular Pressure.

Is NCT05167773 still recruiting?

NCT05167773 is currently completed. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT05167773

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study of the Topcon Tonometer TRK-3

Completed Last updated 20 July 2022

What this trial tests

trial testing tonometer in Intraocular Pressure in 139 participants. Completed in 14 January 2022.

Timeline

11 October 2021

Primary endpoint
14 January 2022

14 January 2022

Quick facts

Lead sponsor	Topcon Corporation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	139
Start date	11 October 2021
Primary completion	14 January 2022
Estimated completion	14 January 2022
Sites	2 locations across Japan

Drugs / interventions tested

tonometer

Conditions studied

Intraocular Pressure — all drugs for Intraocular Pressure →

Sponsor

Topcon Corporation

Who can join

18 and older, any sex, with Intraocular Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will assess the TRK-3 for conformity to ISO 8612:2009, JIS T7312:2015, and ANSI Z80.10-2014 Ophthalmic Instruments - Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification \[510(k)\] Submissions, and the applicable Supplemental Information Sheet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intraocular Pressure

Currently open trials in the same condition.

NCT07274176 — The Effect of Graded Forced Expiration on Intraocular Pressure · NA · recruiting
NCT06666751 — Anterior Segment Optical Coherence Tomography Microstent Positioning · active not recruiting
NCT06016712 — The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes · NA · recruiting
NCT05753137 — Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial · NA · recruiting
NCT05850936 — Effect of IOP Lowering on Progressive HM · NA · active not recruiting

Other Topcon Corporation trials

Trials by the same sponsor.

NCT06733428 — Agreement and Precision Study · completed
NCT06250868 — TRK-3 Performance of Pachymetry · completed
NCT06247072 — TRK-3 Conformance to Standards for Tonometers · completed
NCT06135727 — Screening Protocol · terminated
NCT05286502 — NW500 Non-Mydriatic Retinal Camera Clinical Performance Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05167773 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Topcon Corporation
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05167773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing